Browsing by Author "Bollard NJ"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Effects of nonsteroidal anti-inflammatory drugs, therapeutic hoof trimming, and orthopedic block application on lameness in multiparous dairy cattle: A randomized controlled trial
    (Elsevier Inc for the American Dairy Science Association, USA, 2025-04) Wilson JP; Green MJ; Randall LV; Rutland CS; Bell NJ; Hemingway-Arnold H; Thompson JS; Bollard NJ; Huxley JN
    Hoof horn lesions are recurrent in nature and cause long-term pathological challenges to the functional anatomy of the hoof in dairy cattle. It is hypothesized that inflammation is a driver of these pathological changes. It has previously been identified that routine treatment with nonsteroidal anti-inflammatory drugs (NSAID) at first and subsequent calving and lameness events is important in reducing the future risk of lameness in dairy heifers. The effects NSAID administration has on lameness outcomes for multiparous dairy cattle is unknown. We conducted a 34-mo randomized controlled trial to investigate the effects of routine administration of the NSAID ketoprofen during treatment for lameness and at calving on the future probability of lameness and culling caused by exposure to normal farm conditions. Dairy cattle that had calved at least once were recruited from a single herd and randomly allocated to 1 of 4 treatments controlling for parity, proportion of occasions scored as lame 8 wk before study onset, and DIM. All lactating animals were scored for lameness every 2 wk to identify lame animals requiring treatment. Animals in group 1 received a therapeutic trim and an orthopedic hoof block (if deemed necessary) every time they were treated for lameness. Animals in group 2 received a 3-d course of ketoprofen (single dose daily) alongside the same treatment given in group 1 every time they were treated for lameness. Animals in group 3 received a 3-d course of ketoprofen (single dose daily) starting 24 to 36 h after each calving alongside the same treatment given in group 2 for lameness. Animals in group 4 received a 3-d course of ketoprofen (single dose daily) every time they were identified with lameness, with no therapeutic trim, unless they were identified as severely lame (a single score ≥3a). Animals were followed for the 34-mo duration of the study. Independent lameness outcome scores were collected every 2 wk by technicians who were blinded to treatment group to assess the probability of lameness. Culling data were extracted from farm records. A total of 425 animals were recruited to the study (105 in group 1, 107 in group 2, 107 in group 3, and 106 in group 4), with data from 412 animals included in the final analysis (102 in group 1, 102 in group 2, 106 in group 3, and 102 in group 4). The effect of treatment group on the ongoing probability of lameness was evaluated through the use of mixed effect logistic regression models. Compared with animals in group 1, animals in group 4 were significantly more likely to be identified as lame throughout the study period. No effect on the risk of severe lameness was identified. The effect of group on time to culling was investigated using a Cox proportional hazards model. No benefit of the NSAID or hoof trimming intervention on culling risk was identified. Our results highlight the importance of frequent therapeutic trimming and the application of orthopedic blocks in the treatment of lameness in multiparous animals that may have a history of calving and lameness without NSAID administration.
  • Thumbnail Image
    Item
    Effects of routine treatment with nonsteroidal anti-inflammatory drugs at calving and when lame on the future probability of lameness and culling in dairy cows: A randomized controlled trial
    (Elsevier B.V, 2022-07) Wilson JP; Green MJ; Randall LV; Rutland CS; Bell NJ; Hemingway-Arnold H; Thompson JS; Bollard NJ; Huxley JN
    Claw horn lesions (CHL) are reported as the most common cause of lameness in intensive dairy systems. Despite their prevalence, the underlying pathological mechanisms and preventive strategies for CHL remain poorly understood. Recent advances have pointed to the role of inflammation in disease aetiopathogenesis. Moderating inflammation from first calving may lead to long-term benefits and a viable intervention for treating and preventing disease. We conducted a 34-mo randomized controlled trial to investigate the effects of routine treatment with the nonsteroidal anti-inflammatory drug ketoprofen at calving and during treatment for lameness, on the future probability of lameness and culling, caused by exposure to normal farm conditions. A cohort of dairy heifers were recruited from a single, commercial dairy herd between January 8, 2018, and June 22, 2020, and randomly allocated to one of 4 treatment groups before first calving. The lactating herd was lameness scored every 2 wk on a 0 to 3 scale, to identify animals that became lame (single score ≥2a) and hence required treatment. Animals in group 1 received a therapeutic trim and a hoof block on the sound claw (if deemed necessary) every time they were treated for lameness. Animals in group 2 received the same treatment as group 1 with the addition of a 3-d course of ketoprofen (single dose daily) every time they were treated for lameness. Animals in group 3 received the same treatment as group 2 with the addition of a 3-d course of ketoprofen (single dose daily) starting 24 to 36 h after each calving. Animals in group 4 received a 3-d course of ketoprofen (single dose daily) every time they were identified with lameness. No therapeutic trim was administered to this group, unless they were identified as severely lame (a single score ≥3a). Animals were followed for the duration of the study (ending October 23, 2020). Probability of lameness was assessed by a lameness outcome score collected every 14 d. Data on culling was extracted from farm records. One hundred thirty-two animals were recruited to each group, with data from 438 animals included in the final analysis (111 in group 1, 117 in group 2, 100 in group 3, and 110 in group 4). Mixed effect logistic regression models were used to evaluate the effect of treatment group on the ongoing probability of lameness. Compared with the control group (group 1), animals in group 3 were less likely to become lame (odds ratio: 0.66) and severely lame (odds ratio: 0.28). A Cox proportional hazards survival model was used to investigate the effect of treatment group on time to culling. Compared with group 1, animals in groups 2 and 3 were at reduced risk of culling (hazard ratios: 0.55 and 0.56, respectively). The lameness effect size we identified was large and indicated that treating a cohort of animals with the group 3 protocol, would lead to an absolute reduction in population lameness prevalence of approximately 10% and severe lameness prevalence of 3%, compared with animals treated in accordance with conventional best practice (group 1).